The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...

U.S. President Donald Trump's nominee for director of the CDC was pulled into political contention over U.S. vaccine policy ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

The CDC's vaccine advisory committee voted to recommend annual flu vaccines but against flu shots containing the preservative thimerosal ...

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.